During the past decade, Taihe Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 3 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Taihe Hospital" #1 sponsor was "Hai Li" with 2 trials, followed by "Takeda" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 1 trials sponsored and "Haisco Pharmaceutical Group Co., Ltd." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Taihe Hospital" #1 collaborator was "Affiliated Taihe Hospital of Hubei University of Medicine" with 1 trials as a collaborator, "Beijing Anzhen Hospital" with 1 trials as a collaborator, "Beijing Chao Yang Hospital" with 1 trials as a collaborator, "Beijing Friendship Hospital" with 1 trials as a collaborator and "Beijing Hospital" with 1 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Taihe Hospital" are "Liver Failure, Acute on Chronic" (2 trials), "2019 Novel Coronavirus Infection" (1 trials), "Acute Ischemic Stroke" (1 trials), "Acute Ischemic Stroke AIS" (1 trials) and "Acute Migraine" (1 trials). Many other conditions were trialed in "Taihe Hospital" in a lesser frequency.

Most popular intervention types in "Taihe Hospital" are "Drug" (9 trials), "Device" (2 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Dexlansoprazole" (2 trials), "Standary therapy" (2 trials), "ACT (Acceptance and Commitment Therapy) plus brief CHF education" (1 trials) and "Acarbose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Taihe Hospital" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Taihe Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Taihe Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Taihe Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".